The Global HyperpigmentationTreatment Devices Market, by Product Type (Laser Devices (Q-Switch Lasers,Non-Ablative Fractionated Resurfacing Lasers, Ablative Fractionated ResurfacingLasers, and Picosecond Lasers), Intense Pulsed Light Devices, RadiofrequencyDevices , LED Devices, and Others), by End User (Dermatology Clinics, BeautyCenters, and Others), and by Region (North America, Latin America, Europe, AsiaPacific, Middle East, and Africa) was valued at US$ 1150 Mn in 2017 and isprojected to exhibit a CAGR of 7.2% over the forecast period (2018 – 2026).
Hyperpigmentation is one of themost common skin problems across the globe. According to a study published inthe journal Dermatology Therapy in September 2017, melasma, which is a severehyperpigmentation condition caused due to hormonal changes, has prevalence inthe range of 1% to 50% worldwide. When effective results are not obtained byusing topical treatments, device-based therapies are preferred bydermatologists. According to 2017 Plastic Surgery Statistics Report by theAmerican Society for Plastic Surgeons, around 161,670 ablative and 426,233non-ablative laser skin resurfacing procedures were performed in the U.S. in2017. According to the same source, around 740,287 microdermabrasion procedureswere reported in 2017. Such high number of device-based procedures are expectedto drive growth of the hyperpigmentation treatment devices market. Furthermore,increasing aging population worldwide, especially in developed economies andincreasing disposable income of population in emerging economies such as China,India, and Brazil are expected to fuel growth of the market. According to theInternational Society of Aesthetic Plastic Surgery (ISAPS) report, in 2016,Brazil, India, Turkey, Russia, and China were amongst the top 10 countries indevice-based cosmetic procedures worldwide.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2017
New product launches andacquisitions by key players are expected to drive growth of the hyperpigmentationtreatment devices market
Key players are launchinginnovative products in the hyperpigmentation treatment devices market, in orderto maintain their dominant position in the market. For instance, in July 2018,Candela Corporation was granted with the U.S. Food and Drug Administration(FDA) clearance for its Vbeam Prima, which is an advanced 595 nm pulsed dyelaser that can be used for the treatment of various skin conditions such ashyperpigmentation. In April 2017, BISON MEDICAL’s CYMA clinic CO2 laser systemwas granted with 510(k) clearance from the U.S. FDA. It opened up strong marketsuch as U.S. for this system. In January 2018, Cutera, Inc. launched Juliet andSecret RF to its product offerings of laser- and energy-based devices. Marketplayers are acquiring companies to widen their product portfolio and expandtheir geographical presence. In March 2017, Hologic, Inc. acquired Cynosure,Inc., which is a developer, manufacturer, and supplier of wide range oflight-based aesthetic and medical treatment systems.
Browse 25 Market Data Tables and29 Figures spread through 167 Pages and in-depth TOC on “HyperpigmentationTreatment Devices Market - by Product Type (Laser Devices (Q-Switch Lasers,Non-Ablative Fractionated Resurfacing Lasers, Ablative Fractionated ResurfacingLasers, and Picosecond lasers), Intense Pulsed Light Devices, RadiofrequencyDevices, LED Devices, and Others), by End User (Dermatology Clinics, BeautyCenters, and Others), and by Region(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)”.
Key Takeaways of the HyperpigmentationTreatment Devices Market:
The global hyperpigmentationtreatment devices market is expected to exhibit a CAGR of 7.2% over theforecast period, owing to increasing adoption of minimally invasive skinprocedures using various devices such as laser device and IPL devices
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/hyperpigmentation-treatment-devices-market-2017
Among product type, intense pulselight devices segment is expected to hold dominant position due to highernumber of procedures performed annually using these devices. However, laserdevices segment is expected to exhibit high CAGR over the other products due toseveral new product launches by key players and faster adoption of thesedevices by dermatologists. In the near future, laser devices would surpass IPLdevices for use in hyperpigmentation treatment.
Among end users, dermatologyclinic segment is expected to account for largest market share due to theexpertise they carry in treating severe form of hyperpigmentation andaffordability for costlier laser-based devices
North America is expected to bethe dominant region in the hyperpigmentation treatment devices market, followedby Latin America. According to the International Society of Aesthetic PlasticSurgery (ISAPS) report in 2016, S. accounts for 10% of the overall cosmeticprocedures in the world. Also, key players are launching new products in themarket, which is expected to propel growth of the market in the region.Furthermore, Asia pacific is expected to exhibit highest CAGR due to awarenessabout device-based treatment of hyperpigmentation and availability of skilledhuman resource.
Key players operating in theglobal hyperpigmentation treatment devices market include Syneron Medical Ltd.,Hologic, Inc., Lutronic Corporation, Alma Lasers Ltd., AMI, Venus Concept,Lumenis Ltd., Strata Skin Sciences, Inc., BISON MEDICAL, Cutera Inc., SoltaMedical Inc., Lynton Lasers Ltd., and Sciton, Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2017
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
